Cargando…
Unraveling the Underlying Molecular Mechanism of ‘Silent Hypoxia’ in COVID-19 Patients Suggests a Central Role for Angiotensin II Modulation of the AT1R-Hypoxia-Inducible Factor Signaling Pathway
A few days after being infected with SARS-CoV-2, a fraction of people remain asymptomatic but suffer from a decrease in arterial oxygen saturation in the absence of apparent dyspnea. In light of our clinical investigation on the modulation of molecules belonging to the renin angiotensin system (RAS)...
Autores principales: | Devaux, Christian Albert, Lagier, Jean-Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056466/ https://www.ncbi.nlm.nih.gov/pubmed/36983445 http://dx.doi.org/10.3390/jcm12062445 |
Ejemplares similares
-
Silent Hypoxia in COVID-19: A Case Series
por: Fuehner, Thomas, et al.
Publicado: (2022) -
Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
por: Osman, Ikram Omar, et al.
Publicado: (2021) -
Silent hypoxia in COVID-19: pathomechanism and possible management strategy
por: Rahman, Ahsab, et al.
Publicado: (2021) -
Silent hypoxia is not an identifiable characteristic in patients with COVID-19 infection
por: Plummer, Nicholas Russell, et al.
Publicado: (2022) -
Silent hypoxia in COVID-19: a gut microbiota connection
por: Gopal, Akshita B, et al.
Publicado: (2021)